NCT05000372
- Conditions
- Cancer, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +11 more
- Locations
-
- Beijing Cancer Hospital Beijing, Beijing Municipality, China
Clinical trial condition
Lipodystrophy, Congenital Generalized
Explore clinical trials studying Lipodystrophy, Congenital Generalized. Study availability and eligibility vary by location and protocol.
14 public trials
5 recruiting studies
Lipodystrophy, Congenital Generalized trial results
NCT00896298
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Generalized Lipodystrophy, Genetic Diseases, Inborn, +16 more
- Locations
-
- UT Southwestern Medical Center Dallas, Texas, United States
Completed
Lipodystrophy Connect Patient Registry
NCT02577952
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Laminopathies, +12 more
- Locations
-
- PatientCrossroads San Francisco, California, United States
Active, Not Recruiting
A Study of the Safety of Mibavademab in Pediatric and Adult Participants Switching From Metreleptin to Mibavademab for the Treatment of Generalized Lipodystrophy (GLD)
NCT06548100
- Conditions
- Body Weight, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Diabetes Mellitus, +28 more
- Locations
-
- National Institutes of Health Bethesda, Maryland, United States
- University of Michigan Ann Arbor, Michigan, United States
Related conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities (14)
- Genetic Diseases, Inborn (14)
- Lipid Metabolism Disorders (14)
- Lipid Metabolism, Inborn Errors (14)
- Metabolic Diseases (14)
- Metabolism, Inborn Errors (14)
- Nutritional and Metabolic Diseases (14)
- Skin and Connective Tissue Diseases (14)